Related Experiment Video
Updated: May 14, 2026

4D Printed Bifurcated Stents with Kirigami-Inspired Structures
Published on: July 25, 2019
Evolving coronary stent designs. Journey from substance to sublime
1Fortis Escorts Heart Institute and Research Center, New Delhi, India. kaul.upendra@gmail.com
The global demand for low-cost coronary stents is rising, necessitating innovation. Developing nations can meet this need with new drug-eluting stent (DES) technologies, bridging the gap to bioresorbable scaffolds.
Area of Science:
- Cardiovascular Medicine
- Biomaterials Engineering
- Global Health Economics
Background:
- Coronary artery disease (CAD) presents a significant global healthcare challenge.
- Economic shifts are redefining markets, increasing the demand for affordable medical devices.
- Projected need for coronary stents to reach 10 million units annually within a decade.
Purpose of the Study:
- To address the growing global demand for high-quality, low-cost coronary stents.
- To explore the role of developing nations in meeting future coronary stent requirements.
- To investigate novel drug-eluting stent (DES) engineering concepts.
Main Methods:
- Analysis of global economic trends and technological advancements in medical device manufacturing.
- Review of new concepts in DES engineering, including stent design and drug delivery.
- Assessment of manufacturing capabilities in developing nations.
Main Results:
- Developing nations possess the potential to meet global coronary stent demands due to novel technologies and lower development costs.
- Emerging DES engineering concepts focus on innovative stent designs and drug delivery systems.
- Affordable DES systems are being developed to compete with traditional metal stents and bioresorbable scaffolds.
Conclusions:
- Developing nations are strategically positioned to supply the escalating global demand for coronary stents.
- Innovations in DES technology, particularly in drug delivery and design, are crucial.
- New DES systems aim to bridge the performance and cost gap between current metal stents and future bioresorbable scaffolds.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease II: Pathophysiology
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Coronary Artery Disease I: Introduction
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Acute Coronary Syndrome I: Introduction
